Flixotide Accuhaler (fluticasone propionate): Reviews and patient testimonials

Flixotide Accuhaler

Fluticasone propionate given by inhalation offers preventative treatment for asthma. At recommended doses it has a potent glucocorticoid anti-inflammatory action within the lungs, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Adults: Prophylactic management in:

Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis.

Moderate asthma:Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone.

Severe asthma:Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. On introduction of inhaled fluticasone propionate many of these patients may be able to reduce significantly, or to eliminate, their requirement for oral corticosteroids.

Children: Any child who requires prophylactic medication, including patients not controlled on currently available prophylactic medication.